Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Surg Laparosc Endosc Percutan Tech ; 22(1): e45-7, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22318079

ABSTRACT

Pyoderma gangrenosum (PG) is a rare, chronic, often destructive, inflammatory skin disease in which a painful nodule or pustule breaks down to form a progressively enlarging ulcer. There are only 4 reported cases of postlaparoscopic PG and the purpose of this case report is to describe a patient found to have the disease after elective laparoscopy. Although rare, the occurrence of PG after surgery, even where incisions are small such as in laparoscopic surgery, is a diagnosis that cannot be neglected, especially due to the high morbidity, which increases if the diagnosis is not made and the patient is subjected to debridement.


Subject(s)
Laparoscopy/adverse effects , Pyoderma Gangrenosum/etiology , Adult , Anti-Infective Agents/therapeutic use , Dapsone/therapeutic use , Drug Combinations , Female , Glucocorticoids/therapeutic use , Humans , Prednisolone/therapeutic use
2.
J Crit Care ; 27(3): 319.e9-15, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21855287

ABSTRACT

PURPOSE: The aim of this study was to evaluate echocardiography-based indices of myocardial function and markers of vascular inflammation and endothelial dysfunction in the early phases of severe sepsis. MATERIAL AND METHODS: Forty-five adult patients (67% women; age 51 ± 18 years; Acute Physiology and Chronic Health Disease Classification System II score, 23 ± 7) admitted to the intensive care unit up to 24 hours after fulfilling criteria for severe sepsis or septic shock were studied. Clinical, laboratorial (endothelin 1 [ET1], vascular cellular adhesion molecule 1), and echocardiographic data were collected within the first 24 hours and again 72 hours and 7 days after admission. RESULTS: Intrahospital mortality was 33% (15 deaths). Left ventricular (LV) dysfunction (LV ejection fraction <55%) was identified in 15 (33%) patients, whereas right ventricular (RV) dysfunction (RV tissue Doppler peak systolic velocity [RV-Sm] <12 cm/s) was present in 14 (30%) patients. LogET1 was increased in patients with LV dysfunction (2.3 ± 0.6 vs 1.8 ± 0.4 pg/mL; P = .01) and RV dysfunction (2.5 ± 0.5 vs 1.8 ± 0.4 pg/mL; P < .001) and had negative correlations with LV ejection fraction (r = -0.50; P = .002) and RV-Sm (r = -0.67; P < .001). Left ventricular end-diastolic diameter, RV-Sm, and diastolic dysfunction were able to discriminate survivors from nonsurvivors, and the combination of these parameters identified groups of very low and high risk. CONCLUSION: Both LV and RV systolic dysfunctions are prevalent in severe sepsis, being directly associated with markers of endothelial dysfunction. Left ventricular nondilation, RV dysfunction, and diastolic dysfunction seem related to poor prognosis in this scenario.


Subject(s)
Cardiomyopathy, Dilated/etiology , Endothelium, Vascular/physiopathology , Sepsis/complications , Sepsis/mortality , Ventricular Dysfunction/etiology , Biomarkers/blood , Brazil/epidemiology , Cardiomyopathy, Dilated/diagnostic imaging , Echocardiography , Endothelin-1/blood , Female , Humans , Intercellular Adhesion Molecule-1/blood , Male , Middle Aged , Prognosis , Sepsis/diagnosis , Shock, Septic/complications , Shock, Septic/diagnosis , Shock, Septic/mortality , Survival Rate , Ventricular Dysfunction/diagnostic imaging
3.
J Crit Care ; 27(3): 316.e9-14, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22172795

ABSTRACT

PURPOSE: Noninvasive evaluation of endothelial function may be accomplished by ultrasound assessment of flow-mediated vasodilation (FMD) of the brachial artery. This study aims to investigate the role of FMD analysis on intrahospital prognosis of patients with sepsis. METHODS: Adult patients admitted to the intensive care unit with severe sepsis or septic shock were consecutively included. Brachial artery FMD was measured upon admission, after 24 and 72 hours. A group of apparently healthy subjects paired for sex and age was used as controls. Patients were followed up to discharge or death. RESULTS: We studied 42 patients (mean age, 51 ± 19 years) with sepsis predominantly of abdominal or respiratory etiology (75%). Acute Physiology And Chronic Health Evaluation II risk score was 23 ± 7, and intrahospital mortality rate was 33%. Flow-mediated vasodilation in septic patients was significantly lower than in healthy controls (1.5 ± 7% vs 6 ± 4%, P < .001). Most of the nonsurvivors (86%) showed a decline in sequential FMD analyses, whereas only 43% of survivors showed a reduction of FMD (P = .01). In nonsurvivors, FMD was significantly lower 72 hours after sepsis onset (-3.3% ± 10% vs 5.2% ± 4%; P < .05; time-group interaction P value = .03). CONCLUSIONS: Brachial FMD is altered in septic patients with hemodynamic instability, and its deterioration may be an early marker of unfavorable prognosis.


Subject(s)
Brachial Artery/diagnostic imaging , Endothelium, Vascular/diagnostic imaging , Sepsis/diagnostic imaging , Vasodilation , Case-Control Studies , Female , Humans , Male , Matched-Pair Analysis , Middle Aged , Predictive Value of Tests , Prospective Studies , Shock, Septic/diagnostic imaging , Survival Analysis , Ultrasonography
4.
Article in Portuguese | LILACS | ID: lil-552762

ABSTRACT

A clozapina é uma droga de suma importância para o manejo de pacientes com sintomas psicóticos. Entretanto, efeitos adversos graves como agranulocitose e miocardite podem limitar o seu uso. Apresentamos o caso de um homem de 20 anos de idade que desenvolveu febre e taquicardia alguns dias após o início de uso de clozapina para um provável quadro de esquizofrenia. Após tentativas frustradas de tratamento com antipsicóticos atípicos e lítio, o tratamento com clozapina foi iniciado para controlar sintomas psicóticos. Alguns dias depois, surgiram febre e taquicardia sinusal persistente no eletrocardiograma (ECG). O hemograma revelou leucocitose e eosinofilia. Um ecocardiograma foi realizado e evidenciou aumento do ventrículo esquerdo, hipocinesia difusa e uma fração de ejeção diminuída. Um diagnóstico clínico de miocardite foi feito, e a clozapina foi suspensa, com melhora dos padrões ecocardiográficos e clínicos. A miocardite é um dos muitos potenciais efeitos adversos da clozapina e tem características semelhantes às produzidas pelo ajuste de dose normal da medicação, tornando-se um diagnóstico importante e perigosamente ignorado. Apesar de raros, os efeitos miocárdicos da clozapina podem ser bastante graves, levando ao óbito em alguns casos. Dessa forma, recomenda-se a realização de ECG pré e pós-tratamento e a suspensão da droga caso haja suspeita de acometimento cardíaco.


Clozapine is a useful drug in the treatment of patients with psychotic symptoms. However, severe adverse effects, such as myocarditis and agranulocytosis, can restrict its indications. We present the case of a 20-year-old male who developed fever and tachycardia a few days after initiating treatment with clozapine for a diagnosis of schizophrenia. After unsuccessful treatment attempts with atypical anti-psychotics and lithium, clozapine was initiated to control psychotic symptoms. A few days later, he presented with fever and persistent sinus tachycardia on electrocardiogram (ECG). Blood cell count revealed leukocytosis and eosinophilia. An echocardiogram was performed, which showed left ventricular enlargement, diffuse hypokinesis, and a decreased ejection fraction. A clinical diagnosis of myocarditis was made and clozapine was discontinued, with improvement of both echocardiographic and clinical features. Myocarditis is one of the many potential adverse effects of clozapine and has similar features with its normal dose titration, making it an important and dangerously overlooked diagnosis. Although rare, clozapine’s myocardial effects may be extremely severe, leading to death in some patients. Therefore, it is advisable to obtain an ECG before and after initiating treatment and to immediately discontinue the drug in suspected cases.


Subject(s)
Humans , Male , Adult , Clozapine/adverse effects , Fever , Mentally Ill Persons , Tachycardia , Myocarditis/pathology , Schizophrenia
5.
Arq Bras Cardiol ; 88(1): e10-2, 2007 Jan.
Article in English, Portuguese | MEDLINE | ID: mdl-17364103

ABSTRACT

This article describes a patient presenting with dyspnea and platypnea and whose only clinical finding was presence of patent foramen ovale with a right to left shunt, without pulmonary hypertension, characteristic of the rare Platypnea-Orthodeoxya Syndrome, with very interesting pathophysiological findings and with therapeutic alternatives not yet defined.


Subject(s)
Heart Septal Defects, Atrial/diagnosis , Hypertension, Pulmonary , Aged , Echocardiography , Electrocardiography , Esophagus , Heart Septal Defects, Atrial/surgery , Heart Septum/diagnostic imaging , Heart Septum/surgery , Humans , Male , Respiratory Function Tests , Tomography, X-Ray Computed
6.
Arq. bras. cardiol ; 88(1): e10-e12, jan. 2007. ilus
Article in Portuguese | LILACS | ID: lil-443658

ABSTRACT

Este artigo descreve um paciente que se apresentou com quadro de hipoxemia e platipnéia e cujo único achado na investigação foi a presença de um forame oval patente com shunt direita-esquerda sem hipertensão pulmonar, caracterizando uma síndrome rara conhecida como platipnéia-ortodeoxia, de interessantes características fisiopatológicas e com opções terapêuticas ainda não totalmente definidas.


This article describes a patient presenting with dyspnea and platypnea and whose only clinical finding was presence of patent foramen ovale with a right to left shunt, without pulmonary hypertension, characteristic of the rare Platypnea-Orthodeoxya Syndrome, with very interesting pathophysiological findings and with therapeutic alternatives not yet defined.


Subject(s)
Aged , Humans , Male , Hypertension, Pulmonary , Heart Septal Defects, Atrial/diagnosis , Echocardiography , Electrocardiography , Esophagus , Heart Septal Defects, Atrial/surgery , Heart Septum/surgery , Heart Septum , Respiratory Function Tests , Tomography, X-Ray Computed
8.
Arq Bras Cardiol ; 78(3): 261-6, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11967581

ABSTRACT

OBJECTIVE: To report the hemodynamic and functional responses obtained with clinical optimization guided by hemodynamic parameters in patients with severe and refractory heart failure. METHODS: Invasive hemodynamic monitoring using right heart catheterization aimed to reach low filling pressures and peripheral resistance. Frequent adjustments of intravenous diuretics and vasodilators were performed according to the hemodynamic measurements. RESULTS: We assessed 19 patients (age = 48+/-12 years and ejection fraction = 21+/-5%) with severe heart failure. The intravenous use of diuretics and vasodilators reduced by 12 mm Hg (relative reduction of 43%) pulmonary artery occlusion pressure (P<0.001), with a concomitant increment of 6 mL per beat in stroke volume (relative increment of 24%, P<0.001). We observed significant associations between pulmonary artery occlusion pressure and mean pulmonary artery pressure (r=0.76; P<0.001) and central venous pressure (r=0.63; P<0.001). After clinical optimization, improvement in functional class occurred (P< 0.001), with a tendency towards improvement in ejection fraction and no impairment to renal function. CONCLUSION: Optimization guided by hemodynamic parameters in patients with refractory heart failure provides a significant improvement in the hemodynamic profile with concomitant improvement in functional class. This study emphasizes that adjustments in blood volume result in immediate benefits for patients with severe heart failure.


Subject(s)
Cardiac Catheterization/methods , Heart Failure/physiopathology , Hemodynamics/physiology , Adult , Aged , Blood Pressure/drug effects , Blood Pressure/physiology , Cardiac Output, Low/drug therapy , Cardiac Output, Low/physiopathology , Diuretics/pharmacology , Diuretics/therapeutic use , Female , Furosemide/pharmacology , Furosemide/therapeutic use , Heart Failure/therapy , Hemodynamics/drug effects , Humans , Male , Middle Aged , Nitroprusside/pharmacology , Nitroprusside/therapeutic use , Vasodilator Agents/pharmacology , Vasodilator Agents/therapeutic use
9.
Arq. bras. cardiol ; 78(3): 261-266, Mar. 2002. tab, graf
Article in English | LILACS | ID: lil-305032

ABSTRACT

OBJECTIVE: To report the hemodynamic and functional responses obtained with clinical optimization guided by hemodynamic parameters in patients with severe and refractory heart failure. METHODS: Invasive hemodynamic monitoring using right heart catheterization aimed to reach low filling pressures and peripheral resistance. Frequent adjustments of intravenous diuretics and vasodilators were performed according to the hemodynamic measurements. RESULTS: We assessed 19 patients (age = 48±12 years and ejection fraction = 21±5 percent) with severe heart failure. The intravenous use of diuretics and vasodilators reduced by 12 mm Hg (relative reduction of 43 percent) pulmonary artery occlusion pressure (P<0.001), with a concomitant increment of 6 mL per beat in stroke volume (relative increment of 24 percent, P<0.001). We observed significant associations between pulmonary artery occlusion pressure and mean pulmonary artery pressure (r=0.76; P<0.001) and central venous pressure (r=0.63; P<0.001). After clinical optimization, improvement in functional class occurred (P< 0.001), with a tendency towards improvement in ejection fraction and no impairment to renal function. CONCLUSION: Optimization guided by hemodynamic parameters in patients with refractory heart failure provides a significant improvement in the hemodynamic profile with concomitant improvement in functional class. This study emphasizes that adjustments in blood volume result in imme-diate benefits for patients with severe heart failure


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Cardiac Catheterization , Cardiac Output, Low , Hemodynamics , Blood Pressure , Cardiac Output, Low , Diuretics , Furosemide , Hemodynamics , Nitroprusside , Vasodilator Agents
SELECTION OF CITATIONS
SEARCH DETAIL
...